Global Wealth Management Investment Advisory’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-100
Closed -$6K 665
2019
Q4
$6K Hold
100
﹤0.01% 422
2019
Q3
$6K Hold
100
﹤0.01% 390
2019
Q2
$6K Sell
100
-200
-67% -$12.9K ﹤0.01% 429
2019
Q1
$19K Sell
300
-33
-10% -$1.73K 0.01% 316
2018
Q4
$13K Buy
+333
New +$11.8K 0.01% 351

Other funds holding TNDM

Global Wealth Management Investment Advisory's TNDM Position: Q1 2020 in Review

Global Wealth Management Investment Advisory sold out of Tandem Diabetes Care (TNDM) in Q1 2020, closing a stake of 100 shares — an estimated $6K sold.

Global Wealth Management Investment Advisory first reported a position in TNDM in Q4 2018 and held it in 5 quarters. The position peaked at $19K in Q1 2019. 279 funds tracked by Wall St. Rank hold TNDM as of Q1 2020.

  • Global Wealth Management Investment Advisory reported no remaining Tandem Diabetes Care position as of Q1 2020 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 100 Tandem Diabetes Care shares in Q1 2020, an estimated $6K.
  • Global Wealth Management Investment Advisory first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 5 quarters.
  • Global Wealth Management Investment Advisory's Tandem Diabetes Care position peaked at $19K in Q1 2019.
  • 279 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2020, filed 14 May 2020.